Skip to content

Clinical trials

Hyperphosphatemia trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Country / region: Japan Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20071
20081
20095
20104
20111
20122
20136
20142
20181
20192
20214

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer10
Astellas Pharma Inc8
Kyowa Kirin Co., Ltd.7
Kissei Pharmaceutical Co., Ltd.5
KDL Inc.1
Novartis Pharmaceuticals1
Osaka University1
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia34
Renal Insufficiency, Chronic11
Renal Insufficiency5
Kidney Failure, Chronic2
Vascular Calcification2
Bone Diseases, Metabolic1
Chronic Kidney Disease-Mineral and Bone Disorder1
Kidney Diseases1

Trials

Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.